Food and Drug Administration Center for Devises and Radiological Health. Rockville, MD: U.S. FDA; November 18
Food and Drug Administration Center for Devises and Radiological Health. Executive Summary Dermal Filler Devices. Rockville, MD: U.S. FDA; November 18, 2008
A randomized trial to determine the influence of laser therapy, monopolar radiofrequency treatment, and intense pulsed light therapy administered immediately after hyaluronic acid gel implantation
DOI 10.1111/j.1524-4725.2007.33111.x
Goldman MP, Alster TS, Weiss R. A randomized trial to determine the influence of laser therapy, monopolar radiofrequency treatment an intense pulsed light therapy administered immediately after hyaluronic acid gel implantation. Dermatol Surg 2007;33:535-542 (Pubitemid 46650363)
Management of complications and sequelae with temporary injectable fillers
DOI 10.1097/01.prs.0000248859.14788.60, PII 0000653420071100100014
Alam M, Dover JS. Management of complications and sequelae with termporary injectable fillers. Plast Reconstr Surg 2007;120(6S):98S-105S (Pubitemid 350306749)
Advances in facial rejuvenation: Botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies- Concensus recommendations
and the Facial Aesthetic Consensus Group Faculty
Carruthers JDA, Glogau RG, Blitzer A, and the Facial Aesthetic Consensus Group Faculty. Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies- concensus recommendations. Plast Reconstr Surg 2008;121(5S):5S-30S